Proteotoxic stress of cancer: Implication of the heat-shock response in oncogenesis

Journal of Cellular Physiology

Volumn 227, Issue 8, 2012, Pages 2982-2987

  Dai, Chengkai ^a   Dai, Siyuan ^a   Cao, Junyue ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK TRANSCRIPTION FACTOR 1; PROTEOME;

CANCER SURVIVAL; CARCINOGENESIS; GENE CONTROL; HEAT SHOCK; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY;

CELL TRANSFORMATION, NEOPLASTIC; CYTOPROTECTION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK RESPONSE; HUMANS; NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTORS;

EID: 84860491317     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24017     Document Type: Short Survey

References (77)

1. Ahn SG, Thiele DJ. 2003. Redox regulation of mammalian heat shock factor 1 is essential for Hsp gene activation and protection from stress. Genes Dev 17: 516-528.
2. Akerfelt M, Trouillet D, Mezger V, Sistonen L. 2007. Heat shock factors at a crossroad between stress and development. Ann N Y Acad Sci 1113: 15-27.
3. Anckar J, Sistonen L. 2011. Regulation of HSF1 function in the heat stress response: Implications in aging and disease. Annu Rev Biochem 80: 1089-1115.
4. Balch WE, Morimoto RI, Dillin A, Kelly JW. 2008. Adapting proteostasis for disease intervention. Science 319: 916-919.
5. Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, Tailor P, Morimoto RI, Cohen GM, Green DR. 2000. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2: 469-475.
6. Benjamin IJ, McMillan DR. 1998. Stress (heat shock) proteins: Molecular chaperones in cardiovascular biology and disease. Circ Res 83: 117-132.
7. Birch-Machin I, Gao S, Huen D, McGirr R, White RA, Russell S. 2005. Genomic analysis of heat-shock factor targets in Drosophila. Genome Biol 6: R63.
8. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. 2006. Heat shock proteins in cancer: Chaperones of tumorigenesis. Trends Biochem Sci 31: 164-172.
9. Concannon CG, Orrenius S, Samali A. 2001. Hsp27 inhibits cytochrome c-mediated caspase activation by sequestering both pro-caspase-3 and cytochrome c. Gene Expr 9: 195-201.
10. Craig EA, Gambill BD, Nelson RJ. 1993. Heat shock proteins: Molecular chaperones of protein biogenesis. Microbiol Rev 57: 402-414.
11. Cusack JC. 2003. Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib. Cancer Treat Rev 29: 21-31.
12. Dai C, Whitesell L. 2005. HSP90: A rising star on the horizon of anticancer targets. Future Oncol 1: 529-540.
13. Dai C, Whitesell L, Rogers AB, Lindquist S. 2007. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 130: 1005-1018.
14. Davies MJ. 2005. The oxidative environment and protein damage. Biochim Biophys Acta 1703: 93-109.
15. Dudeja V, Chugh RK, Sangwan V, Skube SJ, Mujumdar NR, Antonoff MB, Dawra RK, Vickers SM, Saluja AK. 2011. Prosurvival role of heat shock factor 1 in the pathogenesis of pancreatobiliary tumors. Am J Physiol Gastrointest Liver Physiol 300: G948-G955.
16. Fang F, Chang R, Yang L. 2011. Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo. Cancer. DOI:10.1002/cncr.26482.
17. Franceschelli S, Rosati A, Lerose R, De Nicola S, Turco MC, Pascale M. 2008. Bag3 gene expression is regulated by heat shock factor 1. J Cell Physiol 215: 575-577.
18. Fu Q, Wang J, Boerma M, Berbee M, Qiu X, Fink LM, Hauer-Jensen M. 2008. Involvement of heat shock factor 1 in statin-induced transcriptional upregulation of endothelial thrombomodulin. Circ Res 103: 369-377.
19. Fujimoto M, Izu H, Seki K, Fukuda K, Nishida T, Yamada S, Kato K, Yonemura S, Inouye S, Nakai A. 2004. HSF4 is required for normal cell growth and differentiation during mouse lens development. EMBO J 23: 4297-4306.
20. Fujimoto M, Takaki E, Hayashi T, Kitaura Y, Tanaka Y, Inouye S, Nakai A. 2005. Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models. J Biol Chem 280: 34908-34916.
21. Fujimoto M, Hayashida N, Katoh T, Oshima K, Shinkawa T, Prakasam R, Tan K, Inouye S, Takii R, Nakai A. 2010. A novel mouse HSF3 has the potential to activate nonclassical heat-shock genes during heat shock. Mol Biol Cell 21: 106-116.
22. Guettouche T, Boellmann F, Lane WS, Voellmy R. 2005. Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress. BMC Biochem 6: 4.
23. Hahn JS, Hu Z, Thiele DJ, Iyer VR. 2004. Genome-wide analysis of the biology of stress responses through heat shock transcription factor. Mol Cell Biol 24: 5249-5256.
24. Hietakangas V, Ahlskog JK, Jakobsson AM, Hellesuo M, Sahlberg NM, Holmberg CI, Mikhailov A, Palvimo JJ, Pirkkala L, Sistonen L. 2003. Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol Cell Biol 23: 2953-2968.
25. Hoang AT, Huang J, Rudra-Ganguly N, Zheng J, Powell WC, Rabindran SK, Wu C, Roy-Burman P. 2000. A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma. Am J Pathol 156: 857-864.
26. Holmberg CI, Hietakangas V, Mikhailov A, Rantanen JO, Kallio M, Meinander A, Hellman J, Morrice N, MacKintosh C, Morimoto RI, Eriksson JE, Sistonen L. 2001. Phosphorylation of serine 230 promotes inducible transcriptional activity of heat shock factor 1. EMBO J 20: 3800-3810.
27. Inouye S, Izu H, Takaki E, Suzuki H, Shirai M, Yokota Y, Ichikawa H, Fujimoto M, Nakai A. 2004. Impaired IgG production in mice deficient for heat shock transcription factor 1. J Biol Chem 279: 38701-38709.
28. Ishiwata J, Kasamatsu A, Sakuma K, Iyoda M, Yamatoji M, Usukura K, Ishige S, Shimizu T, Yamano Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K. 2012. State of heat shock factor 1 expression as a putative diagnostic marker for oral squamous cell carcinoma. Int J Oncol 40: 47-52.
29. Jin X, Moskophidis D, Mivechi NF. 2011a. Heat shock transcription factor 1 is a key determinant of HCC development by regulating hepatic steatosis and metabolic syndrome. Cell Metab 14: 91-103.
30. Jin Y, Zhen Y, Haugsten EM, Wiedlocha A. 2011b. The driver of malignancy in KG-1a leukemic cells, FGFR1OP2-FGFR1, encodes an HSP90 addicted oncoprotein. Cell Signal 23: 1758-1766.
31. Khaleque MA, Bharti A, Sawyer D, Gong J, Benjamin IJ, Stevenson MA, Calderwood SK. 2005. Induction of heat shock proteins by heregulin beta1 leads to protection from apoptosis and anchorage-independent growth. Oncogene 24: 6564-6573.
32. Kim SA, Yoon JH, Lee SH, Ahn SG. 2005. Polo-like kinase 1 phosphorylates heat shock transcription factor 1 and mediates its nuclear translocation during heat stress. J Biol Chem 280: 12653-12657.
33. Koizumi S, Gong P, Suzuki K, Murata M. 2007. Cadmium-responsive element of the human heme oxygenase-1 gene mediates heat shock factor 1-dependent transcriptional activation. J Biol Chem 282: 8715-8723.
34. Lindquist S. 1986. The heat-shock response. Annu Rev Biochem 55: 1151-1191.
35. McMillan DR, Christians E, Forster M, Xiao X, Connell P, Plumier JC, Zuo X, Richardson J, Morgan S, Benjamin IJ. 2002. Heat shock transcription factor 2 is not essential for embryonic development, fertility, or adult cognitive and psychomotor function in mice. Mol Cell Biol 22: 8005-8014.
36. Meng L, Gabai VL, Sherman MY. 2010. Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis. Oncogene 29: 5204-5213.
37. Michel D, Chatelain G, North S, Brun G. 1997. Stress-induced transcription of the clusterin/apoJ gene. Biochem J 328: 45-50.
38. Min JN, Huang L, Zimonjic DB, Moskophidis D, Mivechi NF. 2007. Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene 26: 5086-5097.
39. Morimoto RI. 2008. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 22: 1427-1438.
40. Morimoto RI, Kline MP, Bimston DN, Cotto JJ. 1997. The heat-shock response: Regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem 32: 17-29.
41. Nakamura Y, Fujimoto M, Hayashida N, Takii R, Nakai A, Muto M. 2010. Silencing HSF1 by short hairpin RNA decreases cell proliferation and enhances sensitivity to hyperthermia in human melanoma cell lines. J Dermatol Sci 60: 187-192.
42. Park J, Liu AY. 2001. JNK phosphorylates the HSF1 transcriptional activation domain: Role of JNK in the regulation of the heat shock response. J Cell Biochem 82: 326-338.
43. Ritossa F. 1996. Discovery of the heat shock response. Cell Stress Chaperones 1: 97-98.
44. Santagata S, Hu R, Lin NU, Mendillo ML, Collins LC, Hankinson SE, Schnitt SJ, Whitesell L, Tamimi RM, Lindquist S, Ince TA. 2011. High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci USA 108: 18378-18383.
45. Scott KL, Nogueira C, Heffernan TP, van Doorn R, Dhakal S, Hanna JA, Min C, Jaskelioff M, Xiao Y, Wu CJ, Cameron LA, Perry SR, Zeid R, Feinberg T, Kim M, Vande Woude G, Granter SR, Bosenberg M, Chu GC, DePinho RA, Rimm DL, Chin L. 2011. Proinvasion metastasis drivers in early-stage melanoma are oncogenes. Cancer Cell 20: 92-103.
46. Shamovsky I, Ivannikov M, Kandel ES, Gershon D, Nudler E. 2006. RNA-mediated response to heat shock in mammalian cells. Nature 440: 556-560.
47. Sharma SV, Settleman J. 2007. Oncogene addiction: Setting the stage for molecularly targeted cancer therapy. Genes Dev 21: 3214-3231.
48. Shen HY, He JC, Wang Y, Huang QY, Chen JF. 2005. Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice. J Biol Chem 280: 39962-39969.
49. Sherman M, Multhoff G. 2007. Heat shock proteins in cancer. Ann N Y Acad Sci 1113: 192-201.
50. Sikora K. 2007. Personalized medicine for cancer: From molecular signature to therapeutic choice. Adv Cancer Res 96: 345-369.
51. Silvera D, Formenti SC, Schneider RJ. 2010. Translational control in cancer. Nat Rev Cancer 10: 254-266.
52. Solit DB, Rosen N. 2006. Hsp90: A novel target for cancer therapy. Curr Top Med Chem 6: 1205-1214.
53. Soncin F, Zhang X, Chu B, Wang X, Asea A, Ann Stevenson M, Sacks DB, Calderwood SK, 2003. Transcriptional activity and DNA binding of heat shock factor-1 involve phosphorylation on threonine 142 by CK2. Biochem Biophys Res Commun 303: 700-706.
54. Steele AD, Hutter G, Jackson WS, Heppner FL, Borkowski AW, King OD, Raymond GJ, Aguzzi A, Lindquist S. 2008. Heat shock factor 1 regulates lifespan as distinct from disease onset in prion disease. Proc Natl Acad Sci USA 105: 13626-13631.
55. Tanaka K, Namba T, Arai Y, Fujimoto M, Adachi H, Sobue G, Takeuchi K, Nakai A, Mizushima T. 2007. Genetic evidence for a protective role for heat shock factor 1 and heat shock protein 70 against colitis. J Biol Chem 282: 23240-23252.
56. Tang D, Xie Y, Zhao M, Stevenson MA, Calderwood SK. 2001. Repression of the HSP70B promoter by NFIL6, Ku70, and MAPK involves three complementary mechanisms. Biochem Biophys Res Commun 280: 280-285.
57. Trinklein ND, Murray JI, Hartman SJ, Botstein D, Myers RM. 2004. The role of heat shock transcription factor 1 in the genome-wide regulation of the mammalian heat shock response. Mol Biol Cell 15: 1254-1261.
58. van Doorn R, van Kester MS, Dijkman R, Vermeer MH, Mulder AA, Szuhai K, Knijnenburg J, Boer JM, Willemze R, Tensen CP. 2009. Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome. Blood 113: 127-136.
59. van't Veer LJ, Bernards R. 2008. Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 452: 564-570.
60. Voellmy R. 2004. On mechanisms that control heat shock transcription factor activity in metazoan cells. Cell Stress Chaperones 9: 122-133.
61. Wang J, He H, Yu L, Xia HH, Lin MC, Gu Q, Li M, Zou B, An X, Jiang B, Kung HF, Wong BC. 2006. HSF1 down-regulates XAF1 through transcriptional regulation. J Biol Chem 281: 2451-2459.
62. Westerheide SD, Morimoto RI. 2005. Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem 280: 33097-33100.
63. Westerheide SD, Kawahara TL, Orton K, Morimoto RI. 2006. Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem 281: 9616-9622.
64. Westerheide SD, Anckar J, Stevens SM, Jr., Sistonen L, Morimoto RI. 2009. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 323: 1063-1066.
65. Williams BR, Amon A. 2009. Aneuploidy: Cancer's fatal flaw? Cancer Res 69: 5289-5291.
66. Woo HG, Park ES, Lee JS, Lee YH, Ishikawa T, Kim YJ, Thorgeirsson SS. 2009. Identification of potential driver genes in human liver carcinoma by genomewide screening. Cancer Res 69: 4059-4066.
67. Workman P. 2003. Overview: Translating Hsp90 biology into Hsp90 drugs. Curr Cancer Drug Targets 3: 297-300.
68. Workman P, Burrows F, Neckers L, Rosen N. 2007. Drugging the cancer chaperone HSP90: Combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann N Y Acad Sci 1113: 202-216.
69. Wu C. 1995. Heat shock transcription factors: Structure and regulation. Annu Rev Cell Dev Biol 11: 441-469.
70. Xiao X, Zuo X, Davis AA, McMillan DR, Curry BB, Richardson JA, Benjamin IJ. 1999. HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice. EMBO J 18: 5943-5952.
71. Xie Y, Chen C, Stevenson MA, Auron PE, Calderwood SK. 2002. Heat shock factor 1 represses transcription of the IL-1beta gene through physical interaction with the nuclear factor of interleukin 6. J Biol Chem 277: 11802-11810.
72. Xie Y, Zhong R, Chen C, Calderwood SK. 2003. Heat shock factor 1 contains two functional domains that mediate transcriptional repression of the c-fos and c-fms genes. J Biol Chem 278: 4687-4698.
73. Yokota S, Kitahara M, Nagata K. 2000. Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells. Cancer Res 60: 2942-2948.
74. Yoon YJ, Kim JA, Shin KD, Shin DS, Han YM, Lee YJ, Lee JS, Kwon BM, Han DC. 2011. KRIBB11 inhibits HSP70 synthesis through inhibition of heat shock factor 1 function by impairing the recruitment of positive transcription elongation factor b to the hsp70 promoter. J Biol Chem 286: 1737-1747.
75. Zhang Y, Huang L, Zhang J, Moskophidis D, Mivechi NF. 2002. Targeted disruption of hsf1 leads to lack of thermotolerance and defines tissue-specific regulation for stress-inducible Hsp molecular chaperones. J Cell Biochem 86: 376-393.
76. Zhao R, Ma X, Shen GX. 2008. Transcriptional regulation of plasminogen activator inhibitor-1 in vascular endothelial cells induced by oxidized very low density lipoproteins. Mol Cell Biochem 317: 197-204.
77. Zhao YH, Zhou M, Liu H, Ding Y, Khong HT, Yu D, Fodstad O, Tan M. 2009. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene 28: 3689-3701.